A new synthetic peptide has the potential to deliver medications through the blood brain barrier.
Pericytes could provide novel targets for the treatment and diagnosis of Alzheimer's disease, a new study reports.
Researchers discover a way to traverse the blood-brain barrier and retinal-blood barrier to deliver a molecule which degrades the main component of Alzheimer's plaques.
New research suggests the integrity of the blood brain barrier is compromised for days after an ischemic stroke. This can lead to serious, life threatening complications. Repairing the BBB could prevent further complications.
